| pubmed-article:10326703 | pubmed:abstractText | Combination chemotherapy has dramatically improved the prognosis of patients with nondysgerminomatous ovarian germ cell tumors (NDOGCT). However, guidelines are needed for the identification of patients at risk of relapse. | lld:pubmed |
